Nasdaq: MAZE
Maze Therapeutics insiders
The officers, directors and 10% owners of Maze Therapeutics, Inc. who hold the most stock, valued at the live MAZE price.
$32.43
MAZE today +$1.2M (+3.94%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 6
- Their MAZE stock
- $412M
- Market value
- $1.77B
- Held by ranked insiders
- 23.3%
Insiders by value of MAZE holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Third Rock Ventures IV, L.P. | 10% owner | 7,024,758 | $228M | 12.8% | Corporate |
| 2 | Third Rock Ventures GP V, LP | 10% owner | 4,473,958 | $145M | 8.18% | Corporate |
| 3 | Jason Coloma V. | Chief Executive Officer | 537,736 | $17.4M | 0.98% | 5362nd |
| 4 | Jonathan E. Lim | Director | 328,700 | $10.7M | 0.60% | 390th |
| 5 | Trv GP V, LLC | 10% owner | 311,170 | $10.1M | 0.57% | Corporate |
| 6 | Charles J. Homcy | Director | 38,535 | $1.2M | <0.1% | 1924th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Maze Therapeutics; see each profile for the filing.